Three new studies reveal surprising insights into GLP-1 weight-loss drugs, opioid therapy in pregnancy, and the underlying science behind wellness. CLEVELAND – Check out Tuesday’s Daily Feed from 3 News Senior Health Correspondent Monica Robbins… Stopping your weight loss medication? You may not get as much back as you think If you’ve stopped taking … Read more
A new study suggests that people who stop taking a drug like Ozympic lose about 25 percent of their weight after a year. But here’s the catch: It doesn’t know if that weight loss is muscle rather than fat. This medical mystery sheds light on the undiscovered side effects of semaglutide, terzapatide, and other drugs … Read more
Welcome to The Thin Line, a New York Post series on the dark side of GLP-1 drugs. Although GLP-1 agonists sold under brand names like Ozympic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
Analysts note that this Phase II readout puts aliglipron in line to challenge other oral GLP-1RAs on the market if it has shown Phase III success. Credit: New Africa / Shutterstock.com. Structure Therapy’s oral weight-loss drug, alaniglipron, has led to strong weight loss in a Phase II obesity trial — results that analysts suggest put … Read more
One study found that 55% of obese people regained the weight they lost after stopping GLP-1 medication, and so did 45% of diabetics. It also found that 45% of obese participants and 56% of diabetics lost weight or kept it off while off the medication. However, many of those who had successful outcomes still received … Read more
Open this image in the gallery: Boxes of semaglutide injection pens on shelves inside the refrigerator at Durham Care Clinic and Pharmacy in Oshawa, Ont. Obesity experts say one solution to help those who are prescribed by their doctors but can’t afford it financially is public health plans.Eduardo Lima/Globe and Mail When Bonnie Ivy entered … Read more
In late 2025, the nonprofit KFF Health Policy Organization released the results of a survey that found that about one in eight Americans were taking GLP-1 drugs for weight loss or another health condition. Eighty percent of respondents reported having taken drugs in the past, and expected to continue using drugs. announcement Cleveland Clinic is … Read more
The city’s chief financial officer, Ashley Groffenberger, sent a letter to the City Council on Monday saying that health insurance rates for city employees are increasing nearly 23 percent in the fiscal year that begins in July — the highest year-over-year premium costs the city has seen “in recent history.” According to the city, Boston … Read more
Wu’s administration is considering cutting GLP-1 coverage for weight loss for Boston city workers because of “skyrocketing” health insurance costs that are straining city finances. Chief Finance Officer Ashley Groffenberger said in a letter to the Boston City Council on Monday that the city has confirmed that there will be a significant increase in employee … Read more
Overall obesity among US high school students has increased from 13.7% in 2013 to 15.9% in 2023 and 16.3% in 2021. Three main methods of RT: Youth obesity rates are on the rise in the United States: A Florida Atlantic University study published in the Ochsner Journal found that obesity among US high school students … Read more